Temerty Centre Speaker Series: Dr. Shaf Keshavjee & Dr. Andrew Sage
DATE: April 2, 2025 (Wed.)
TIME: 11am to 12pm ET
METHOD: Online (Zoom)
PRESENTERS: Dr. Shaf Keshavjee & Dr. Andrew Sage
TALK TITLE: Machine Learning and Artificial Intelligence in Assessing Organ Injury and Predicting Patient Outcomes in Lung Transplantation
NOTE: This event is CPD-accredited for physicians
Title
Machine Learning and Artificial Intelligence in Assessing Organ Injury and Predicting Patient Outcomes in Lung Transplantation
Description
This presentation explores how machine learning (ML) and artificial intelligence (AI) are advancing predictive analytics and decision-making in thoracic surgery. It highlights the role of novel biomedical technologies, particularly ex vivo organ perfusion, as a key driver of ML innovation in transplantation.
Learning Objectives
By the end of this presentation, attendees will learn how:
• To gain a clear understanding of lung transplant data structures
• To apply machine learning techniques to predict lung transplant outcomes
• To understand the process of integrating algorithms into clinical practice to enhance real-world transplant decision-making.
About the Co-Presenter
Dr. Shaf Keshavjee is a world-renowned thoracic surgeon-scientist with a history of breakthroughs and discoveries in lung transplantation. He is the current Surgeon-in-Chief of the Sprott Department of Surgery, the Director of the Toronto Lung Transplant Program and Latner Thoracic Research Laboratories at UHN, and Professor of Thoracic Surgery at the University of Toronto.
Dr. Keshavjee completed his medical training at the University of Toronto in 1985, and specialized in General Surgery, Cardiac Surgery and Thoracic Surgery. He participated in the world’s first successful double lung transplant at Toronto General Hospital in 1986. Dr. Keshavjee completed fellowships at Harvard University and the University of London. During his Master’s studies, Dr. Keshavjee developed a lung preservation solution for donor lungs that has now been translated into clinical use around the world. Since then, he has led the development and translation of many innovations to the clinic, including the Ex Vivo Lung Perfusion (EVLP) system. More...
About the Co-Presenter
Dr. Andrew Sage is an Assistant Scientist with the Toronto Lung Transplant Program at the Toronto General Hospital Research Institute and an Assistant Professor at the University of Toronto. With a background in biochemistry and pharmaceutical sciences, his research focuses on identifying and translating novel biomarkers and medical devices to enhance surgical decision-making in lung transplantation. He is a leader in integrating cutting-edge technologies such as machine learning, artificial intelligence, and digital twins of human organs. In 2021, he was instrumental in the world’s first drone-delivered human lung transplant in Toronto. More...
